Related Experiment Video
Updated: Aug 6, 2025

Breast Milk Enhances Growth of Enteroids: An Ex Vivo Model of Cell Proliferation
Published on: February 15, 2018
Current and future methods of probiotic therapy for necrotizing enterocolitis
Nitin Sajankila1, Samantha Jane Wala1, Mecklin Victoria Ragan1
1Department of Pediatric Surgery, Center for Perinatal Research, Nationwide Children's Hospital, Columbus, OH, United States.
Insights
Necrotizing enterocolitis (NEC) prevention in premature infants remains a challenge. Probiotics show promise, but further research and product development are needed to establish clear guidelines for their safe and effective use in neonates.
Area of Science:
- Neonatal Medicine
- Gastroenterology
- Microbiology
Background:
- Necrotizing enterocolitis (NEC) is a severe intestinal disease affecting premature infants, with high mortality and morbidity.
- Current prophylactic measures are insufficient, creating a need for novel preventative strategies.
- Probiotics are being investigated as a potential preventative therapy for NEC.
Purpose of the Study:
- To review the current evidence on probiotics for NEC prevention in neonates.
- To discuss the challenges and future directions for probiotic use in this population.
- To explore next-generation probiotics and novel delivery strategies.
Main Methods:
- Literature review of studies on probiotics and NEC.
- Discussion of current probiotic products, safety, and efficacy concerns.
- Exploration of emerging probiotic technologies and delivery methods.
Main Results:
- There is significant interest in probiotics for NEC, but no clear guidelines or FDA-approved products exist.
- Evidence regarding the benefits of probiotics in neonates is inconsistent, with safety and efficacy concerns.
- Next-generation probiotics and novel delivery systems may offer improved risk-benefit profiles.
Conclusions:
- Probiotics hold potential as an effective NEC prevention strategy.
- Further research and product development are essential to optimize probiotic use in preterm infants.
- Addressing safety and efficacy concerns is crucial for clinical implementation.
Abstract:
Necrotizing enterocolitis (NEC) is a complex intestinal disease that primarily affects premature neonates. Given its significant mortality and morbidity, there is an urgent need to develop improved prophylactic measures against the disease. One potential preventative strategy for NEC is the use of probiotics. Although there has been significant interest for decades in probiotics in neonatal care, no clear guidelines exist regarding which probiotic to use or for which patients, and no FDA-approved products exist on the market for NEC. In addition, there is lack of agreement regarding the benefits of probiotics in neonates, as well as some concerns about the safety and efficacy of available products. We discuss currently available probiotics as well as next-generation probiotics and novel delivery strategies which may offer an avenue to capitalize on the benefits of probiotics, while minimizing the risks. Thus, probiotics may still prove to be an effective prevention strategy for NEC, although further product development and research is needed to support use in the preterm population.
Related Concept Videos
Microorganisms in Medicine and Therapeutics
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Biological Methods for Microbial Control

